BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Magkou D, Tziomalos K. Antidiabetic treatment, stroke severity and outcome. World J Diabetes 2014; 5(2): 84-88 [PMID: 24748923 DOI: 10.4239/wjd.v5.i2.84]
URL: https://www.wjgnet.com/1948-9358/full/v5/i2/84.htm
Number Citing Articles
1
L. Castilla-Guerra, M.C. Fernández-Moreno, J. Hewitt. Tratamiento de la hiperglucemia en pacientes con ictus agudoRevista Clínica Española 2016; 216(2): 92 doi: 10.1016/j.rce.2015.06.005
2
Fu-Shun Yen, Jen-Huai Chiang, Chun-Wei Pan, Boniface J. Lin, James Cheng-Chung Wei, Chih-Cheng Hsu. Cardiovascular outcomes of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes on insulin therapyDiabetes Research and Clinical Practice 2018; 140: 279 doi: 10.1016/j.diabres.2018.04.012
3
Suehyun Lee, Seongwoo Jeon, Hun-Sung Kim. A Study on Methodologies of Drug Repositioning Using Biomedical Big Data: A Focus on Diabetes MellitusEndocrinology and Metabolism 2022; 37(2): 195 doi: 10.3803/EnM.2022.1404
4
Maryam A. Salaudeen, Nura Bello, Rabiu N. Danraka, Maryam L. Ammani. Understanding the Pathophysiology of Ischemic Stroke: The Basis of Current Therapies and Opportunity for New OnesBiomolecules 2024; 14(3): 305 doi: 10.3390/biom14030305
5
Vishal Chavda, Snehal Patel. Hyperglycaemic Metabolic Complications of Ischemic Brain: Current Therapeutics, Anti-Diabetics and Stem Cell TherapyCNS & Neurological Disorders - Drug Targets 2023; 22(6): 832 doi: 10.2174/1871527321666220609200852
6
Jia Guo, Hailan Wang, Xin Jiang, Yan Wang, Zhihao Zhang, Qingbin Liao, Jia Xu, Xiaohan Ren. An Untargeted Lipidomics Study of Acute Ischemic Stroke with Hyperglycemia Based on Ultrahigh-Performance Liquid Chromatography-Mass SpectrometryComputational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/8332278
7
Konstantinos Tziomalos, Panagiotis Dimitriou, Stella D. Bouziana, Marianna Spanou, Stavroula Kostaki, Stella-Maria Angelopoulou, Maria Papadopoulou, Vasilios Giampatzis, Christos Savopoulos, Apostolos I. Hatzitolios. Stress hyperglycemia and acute ischemic stroke in-hospital outcomeMetabolism 2017; 67: 99 doi: 10.1016/j.metabol.2016.11.011
8
Konstantinos Tziomalos, Stella D Bouziana, Marianna Spanou, Stavroula Kostaki, Maria Papadopoulou, Vasilios Giampatzis, Vasiliki Dourliou, Danai-Thomais Kostourou, Christos Savopoulos, Apostolos I Hatzitolios. Prior treatment with dipeptidyl peptidase 4 inhibitors is associated with better functional outcome and lower in-hospital mortality in patients with type 2 diabetes mellitus admitted with acute ischaemic strokeDiabetes and Vascular Disease Research 2015; 12(6): 463 doi: 10.1177/1479164115597867
9
Vladimer Darsalia, Thomas Klein, Thomas Nyström, Cesare Patrone. Glucagon-like receptor 1 agonists and DPP-4 inhibitors: Anti-diabetic drugs with anti-stroke potentialNeuropharmacology 2018; 136: 280 doi: 10.1016/j.neuropharm.2017.08.022
10
L. Castilla-Guerra, M.C. Fernández-Moreno, J. Hewitt. Treatment of hyperglycemia in patients with acute strokeRevista Clínica Española (English Edition) 2016; 216(2): 92 doi: 10.1016/j.rceng.2015.08.002
11
Olaf Eberhardt, Helge Topka. Neurological outcomes of antidiabetic therapy: What the neurologist should knowClinical Neurology and Neurosurgery 2017; 158: 60 doi: 10.1016/j.clineuro.2017.04.014
12
Yohei Mima, Takahiro Kuwashiro, Masahiro Yasaka, Yuichiro Tsurusaki, Asako Nakamura, Yoshiyuki Wakugawa, Yasushi Okada. Impact of Metformin on the Severity and Outcomes of Acute Ischemic Stroke in Patients with Type 2 Diabetes MellitusJournal of Stroke and Cerebrovascular Diseases 2016; 25(2): 436 doi: 10.1016/j.jstrokecerebrovasdis.2015.10.016
13
Debarati Ghosh, Karan Sehgal, Babasaheb Sodnar, Nikhil Bhosale, Deepaneeta Sarmah, Aishika Datta, Antra Chaudhary, Kiran Kalia, Xin Wang, Pallab Bhattacharya. Drug repurposing for stroke interventionDrug Discovery Today 2022; 27(7): 1974 doi: 10.1016/j.drudis.2022.03.003
14
Gang Zhang, Samuel Kim, Xiaohuan Gu, Shan Ping Yu, Ling Wei. DPP-4 Inhibitor Linagliptin is Neuroprotective in Hyperglycemic Mice with Stroke via the AKT/mTOR Pathway and Anti-apoptotic EffectsNeuroscience Bulletin 2020; 36(4): 407 doi: 10.1007/s12264-019-00446-w
15
Vladimer Darsalia, Martin Larsson, David Nathanson, Thomas Klein, Thomas Nyström, Cesare Patrone. Glucagon-Like Receptor 1 Agonists and DPP-4 Inhibitors: Potential Therapies for the Treatment of StrokeJournal of Cerebral Blood Flow & Metabolism 2015; 35(5): 718 doi: 10.1038/jcbfm.2015.17
16
Vishal Chavda, Bipin Chaurasia, Harsh Deora, Giuseppe Emmanuele Umana. Chronic Kidney disease and stroke: A Bi-directional risk cascade and therapeutic updateBrain Disorders 2021; 3: 100017 doi: 10.1016/j.dscb.2021.100017
17
Kazo Kanazawa, Nobukazu Miyamoto, Kenichiro Hira, Chikage Kijima, Yuji Ueno, Nobutaka Hattori. Baseline platelet count may predict short-term functional outcome of cerebral infarctionBMC Neurology 2022; 22(1) doi: 10.1186/s12883-022-02845-5
18
Francesco Paneni, Francesco Cosentino. Diabetes and Cardiovascular Disease2015; : 189 doi: 10.1007/978-3-319-17762-5_15
19
F. Barkas, M. Elisaf, V. Tsimihodimos, H. Milionis. Dipeptidyl peptidase-4 inhibitors and protection against stroke: A systematic review and meta-analysisDiabetes & Metabolism 2017; 43(1): 1 doi: 10.1016/j.diabet.2016.10.006
20
Isaac Arbeláez-Quintero, Mauricio Palacios. To Use or Not to Use Metformin in Cerebral Ischemia: A Review of the Application of Metformin in Stroke RodentsStroke Research and Treatment 2017; 2017: 1 doi: 10.1155/2017/9756429